Rainer Storb

97.8k total citations · 19 hit papers
1.1k papers, 67.2k citations indexed

About

Rainer Storb is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Rainer Storb has authored 1.1k papers receiving a total of 67.2k indexed citations (citations by other indexed papers that have themselves been cited), including 822 papers in Hematology, 285 papers in Immunology and 249 papers in Genetics. Recurrent topics in Rainer Storb's work include Hematopoietic Stem Cell Transplantation (753 papers), Mesenchymal stem cell research (167 papers) and Acute Myeloid Leukemia Research (152 papers). Rainer Storb is often cited by papers focused on Hematopoietic Stem Cell Transplantation (753 papers), Mesenchymal stem cell research (167 papers) and Acute Myeloid Leukemia Research (152 papers). Rainer Storb collaborates with scholars based in United States, South Africa and Germany. Rainer Storb's co-authors include H. Joachim Deeg, Brenda M. Sandmaier, E. Donnall Thomas, Barry E. Storer, CD Buckner, David G. Maloney, Paul J. Martin, Frederick R. Appelbaum, Keith M. Sullivan and Michael B. Maris and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Rainer Storb

1.1k papers receiving 64.3k citations

Hit Papers

Hematopoietic cell transplantat... 1970 2026 1988 2007 2005 1980 1998 2010 1975 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
    2005 2.0k citations Mohamed L. Sorror, Michael B. Maris et al. Blood profile →
  2. Chronic graft-versus-host syndrome in man
    1980 1.9k citations Rainer Storb et al. profile →
  3. Evidence for Circulating Bone Marrow-Derived Endothelial Cells
    1998 1.3k citations Rainer Storb et al. Blood profile →
  4. Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
    2010 1.0k citations Ted Gooley, Mohamed L. Sorror et al. profile →
  5. Bone-Marrow Transplantation
    1975 926 citations E. Donnall Thomas, Rainer Storb et al. profile →
  6. Antileukemic Effect of Chronic Graft-versus-Host Disease
    1981 849 citations Rainer Storb et al. profile →
  7. Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic Cancers
    2001 700 citations William Bensinger, Paul J. Martin et al. profile →
  8. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression
    1981 692 citations Rainer Storb, PL Weiden et al. Blood profile →
  9. Solid Cancers after Bone Marrow Transplantation
    1997 677 citations H. Joachim Deeg, Rainer Storb et al. profile →
  10. Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
    1995 529 citations Scott D. Rowley, Rainer Storb et al. Journal of Clinical Oncology profile →
  11. Allogeneic Bone‐Marrow Transplantation
    1983 495 citations Rainer Storb et al. profile →
  12. Stable Mixed Hematopoietic Chimerism in DLA-Identical Littermate Dogs Given Sublethal Total Body Irradiation Before and Pharmacological Immunosuppression After Marrow Transplantation
    1997 492 citations Rainer Storb, H. Joachim Deeg et al. Blood profile →
  13. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]
    1989 468 citations PL Weiden, Rainer Storb et al. Blood profile →
  14. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
    2011 453 citations Mary E.D. Flowers, Yoshihiro Inamoto et al. Blood profile →
  15. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality
    1976 435 citations Thomas Ed, Rainer Storb et al. Blood profile →
  16. Technique for Human Marrow Grafting
    1970 380 citations Rainer Storb et al. Blood profile →
  17. METHOTREXATE REGIMENS FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS WITH ALLOGENEIC MARROW GRAFTS
    1970 226 citations Rainer Storb, E. Donnall Thomas et al. profile →
  18. Marrow Transplantation for Treatment of Aplastic Anemia
    1977 223 citations Rainer Storb, E. Donnall Thomas et al. profile →
  19. Marrow Transplantation for Treatment of Aplastic Anaemia
    1978 219 citations Rainer Storb, E. Donnall Thomas profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rainer Storb United States 126 48.8k 19.1k 15.7k 11.9k 10.2k 1.1k 67.2k
Richard E. Champlin United States 113 27.2k 0.6× 12.6k 0.7× 14.9k 1.0× 8.4k 0.7× 7.1k 0.7× 1.1k 45.3k
Olle Ringdén Sweden 91 18.2k 0.4× 9.4k 0.5× 7.7k 0.5× 14.7k 1.2× 4.0k 0.4× 680 39.3k
Daniel J. Weisdorf United States 96 24.2k 0.5× 13.3k 0.7× 11.4k 0.7× 5.1k 0.4× 6.3k 0.6× 732 38.4k
Arnon Nagler Israel 88 21.6k 0.4× 12.6k 0.7× 12.5k 0.8× 6.0k 0.5× 5.4k 0.5× 1.1k 39.3k
Frederick R. Appelbaum United States 105 30.9k 0.6× 7.0k 0.4× 10.1k 0.6× 8.9k 0.8× 10.6k 1.0× 595 42.6k
Éliane Gluckman France 93 19.2k 0.4× 7.8k 0.4× 6.5k 0.4× 6.9k 0.6× 3.6k 0.4× 627 29.5k
Bruce R. Blazar United States 119 20.2k 0.4× 36.0k 1.9× 16.5k 1.1× 5.0k 0.4× 2.5k 0.2× 843 58.3k
H. Joachim Deeg United States 94 23.2k 0.5× 6.8k 0.4× 7.1k 0.5× 6.4k 0.5× 5.6k 0.5× 669 31.0k
Paul J. Martin United States 98 20.5k 0.4× 12.4k 0.6× 6.9k 0.4× 4.5k 0.4× 4.9k 0.5× 568 34.2k
Franco Locatelli Italy 88 12.5k 0.3× 9.9k 0.5× 8.4k 0.5× 8.1k 0.7× 3.7k 0.4× 1.0k 33.0k

Countries citing papers authored by Rainer Storb

Since Specialization
Citations

This map shows the geographic impact of Rainer Storb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Storb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Storb more than expected).

Fields of papers citing papers by Rainer Storb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer Storb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Storb. The network helps show where Rainer Storb may publish in the future.

Co-authorship network of co-authors of Rainer Storb

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer Storb. A scholar is included among the top collaborators of Rainer Storb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer Storb. Rainer Storb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morsink, Linde M., Megan Othus, Filippo Milano, et al.. (2022). Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML. Blood. 139(11). 1694–1706. 47 indexed citations
2.
Puronen, Camille E., Ryan D. Cassaday, Philip A. Stevenson, et al.. (2018). Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation–Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma. Biology of Blood and Marrow Transplantation. 24(11). 2211–2215. 8 indexed citations
3.
Flowers, Mary E.D., Yoshihiro Inamoto, Paul A. Carpenter, et al.. (2011). Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood. 117(11). 3214–3219. 453 indexed citations breakdown →
4.
Nishida, Tetsuya, Michael Hudecek, Ana Kostić, et al.. (2009). Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia. Clinical Cancer Research. 15(14). 4759–4768. 31 indexed citations
5.
Nakamae, Hirohisa, D. Scott Wilbur, Donald K. Hamlin, et al.. (2009). Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211. Cancer Research. 69(6). 2408–2415. 43 indexed citations
6.
Rotta, Marcello, Barry E. Storer, Firoozeh Sahebi, et al.. (2008). Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. Blood. 113(14). 3383–3391. 71 indexed citations
7.
Sorror, Mohamed L., Barry E. Storer, Brenda M. Sandmaier, et al.. (2008). Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning. Journal of Clinical Oncology. 26(30). 4912–4920. 182 indexed citations
8.
Rezvani, Andrew R. & Rainer Storb. (2008). Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. Journal of Autoimmunity. 30(3). 172–179. 48 indexed citations
9.
Maris, Michael B., Brenda M. Sandmaier, Barry E. Storer, et al.. (2006). Unrelated Donor Granulocyte Colony-Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cell Transplantation after Nonmyeloablative Conditioning: The Effect of Postgrafting Mycophenolate Mofetil Dosing. Biology of Blood and Marrow Transplantation. 12(4). 454–465. 75 indexed citations
10.
Sorror, Mohamed L., Michael B. Maris, Rainer Storb, et al.. (2005). Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 106(8). 2912–2919. 1977 indexed citations breakdown →
11.
Hegenbart, Ute, Dietger Niederwieser, Brenda M. Sandmaier, et al.. (2005). Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors. Journal of Clinical Oncology. 24(3). 444–453. 181 indexed citations
12.
Flowers, Mary E.D., Carlos Roberto de Medeiros, Marco A. Bitencourt, et al.. (2005). Low‐dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA‐matched related donors in patients with Fanconi anaemia. British Journal of Haematology. 130(1). 99–106. 33 indexed citations
13.
Deeg, H. Joachim, Kristy Seidel, David S. Hong, et al.. (1997). In vivo radioprotective effect of AcSDKP on canine myelopoiesis. Annals of Hematology. 74(3). 117–122. 10 indexed citations
14.
Anderson, Jeanne E., et al.. (1997). Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis. British Journal of Haematology. 98(4). 1010–1016. 55 indexed citations
15.
Demirer, Taner, Ted Gooley, CD Buckner, et al.. (1995). Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.. PubMed. 15(6). 907–13. 51 indexed citations
16.
Anderson, Jeanne E., Frederick R. Appelbaum, & Rainer Storb. (1995). An Update on Allogeneic Marrow Transplantation for Myelodysplastic Syndrome. Leukemia & lymphoma. 17(1-2). 95–99. 34 indexed citations
17.
Ladiges, Warren, et al.. (1984). Monoclonal Antibodies to Canine Cell Surface Antigens: A Comparison of Screening Assays. Hybridoma. 3(4). 387–390. 2 indexed citations
18.
Kolb, H., G E Sale, K. G. Lerner, Rainer Storb, & E. Donnall Thomas. (1979). Pathology of acute graft-versus-host disease in the dog. An autopsy study of ninety-five dogs.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 96(2). 581–94. 28 indexed citations
19.
Storb, Rainer, et al.. (1977). Studies on Cellular Inhibition and Serum-Blocking Factors in 28 Human Patients Given Marrow Grafts from HLA Identical Siblings. The Journal of Immunology. 118(5). 1799–1805. 6 indexed citations
20.
Weiden, PL, Thomas Ed, Rainer Storb, et al.. (1976). Marrow transplantation in aplastic anemia and leukemia.. Comprehensive Therapy. 2(4). 57–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard E. Champlin Breakdown of academic impact, for papers by Olle Ringdén Breakdown of academic impact, for papers by Daniel J. Weisdorf Breakdown of academic impact, for papers by Arnon Nagler Breakdown of academic impact, for papers by Frederick R. Appelbaum Breakdown of academic impact, for papers by Éliane Gluckman Breakdown of academic impact, for papers by Bruce R. Blazar Breakdown of academic impact, for papers by H. Joachim Deeg Breakdown of academic impact, for papers by Paul J. Martin Breakdown of academic impact, for papers by Franco Locatelli
Rankless by CCL
2026